Using fluorine to improve biomaterials and biotechnology
Harnessing the orthogonality of fluorine for advanced biomaterials and biotechnologies
This study is exploring new ways to use special compounds to improve treatments and tests for diseases like cancer and tough infections, aiming to create personalized therapies that work better for each patient.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11011906 on NIH RePORTER |
What this research studies
This research focuses on the unique properties of fluorinated compounds to enhance medical therapies and diagnostics. By designing specialized molecules that can interact with perfluorinated compounds, the team aims to create new tools for detecting and treating diseases like cancer and drug-resistant infections. The approach involves developing nanoemulsions that can carry therapeutic agents and be tailored for individual patient needs. This innovative methodology could lead to more effective and personalized treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with cancer, inflammatory diseases, or drug-resistant infections.
Not a fit: Patients with non-complex or non-metabolic diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to advanced therapies and diagnostics that are more effective for patients with complex diseases.
How similar studies have performed: Other research has shown promise in using fluorinated compounds for medical applications, indicating a potential for success in this novel approach.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Sletten, Ellen May — University of California Los Angeles
- Study coordinator: Sletten, Ellen May
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.